IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer
about
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical reviewCPA-7 influences immune profile and elicits anti-prostate cancer effects by inhibiting activated STAT3.G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells.PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer.Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.
P2860
IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@ast
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@en
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@nl
type
label
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@ast
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@en
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@nl
prefLabel
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@ast
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@en
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@nl
P2093
P3181
P356
P1433
P1476
IL-6/STAT3/ARF: the guardians ...... metastasis in prostate cancer
@en
P2093
Jan Pencik
Martin Susani
Robert Wiebringhaus
Zoran Culig
P304
P3181
P356
10.4414/SMW.2015.14215
P407
P50
P577
2015-12-21T00:00:00Z